- Home
- BWA vs AXSM Comparison
BWA vs AXSM Comparison
Compare BWA & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWA
- AXSM
- Stock Information
- Founded
- BWA 1987
- AXSM 2012
- Country
- BWA United States
- AXSM United States
- Employees
- BWA N/A
- AXSM N/A
- Industry
- BWA Auto Parts:O.E.M.
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- BWA Consumer Discretionary
- AXSM Health Care
- Exchange
- BWA Nasdaq
- AXSM Nasdaq
- Market Cap
- BWA 6.3B
- AXSM 5.1B
- IPO Year
- BWA 1993
- AXSM 2015
- Fundamental
- Price
- BWA $34.98
- AXSM $111.70
- Analyst Decision
- BWA Buy
- AXSM Strong Buy
- Analyst Count
- BWA 13
- AXSM 17
- Target Price
- BWA $40.00
- AXSM $171.65
- AVG Volume (30 Days)
- BWA 2.1M
- AXSM 618.2K
- Earning Date
- BWA 07-31-2025
- AXSM 08-04-2025
- Dividend Yield
- BWA 1.26%
- AXSM N/A
- EPS Growth
- BWA N/A
- AXSM N/A
- EPS
- BWA 1.30
- AXSM N/A
- Revenue
- BWA $14,006,000,000.00
- AXSM $432,157,000.00
- Revenue This Year
- BWA $0.46
- AXSM $62.57
- Revenue Next Year
- BWA $3.36
- AXSM $59.96
- P/E Ratio
- BWA $26.89
- AXSM N/A
- Revenue Growth
- BWA N/A
- AXSM 72.16
- 52 Week Low
- BWA $24.40
- AXSM $72.21
- 52 Week High
- BWA $37.29
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- BWA 56.09
- AXSM 58.82
- Support Level
- BWA $34.80
- AXSM $108.48
- Resistance Level
- BWA $35.61
- AXSM $113.48
- Average True Range (ATR)
- BWA 0.69
- AXSM 3.35
- MACD
- BWA -0.06
- AXSM 0.69
- Stochastic Oscillator
- BWA 62.37
- AXSM 76.10
About BWA BorgWarner Inc.
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2023, 25% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.